| Literature DB >> 26950369 |
Jie Yin1, Kerim Babaoglu2, Chad A Brautigam1, Lindsay Clark1, Zhenhua Shao1, Thomas H Scheuermann1, Charles M Harrell3, Anthony L Gotter3, Anthony J Roecker4, Christopher J Winrow3, John J Renger3, Paul J Coleman4, Daniel M Rosenbaum1.
Abstract
The orexin (also known as hypocretin) G protein-coupled receptors (GPCRs) regulate sleep and other behavioral functions in mammals, and are therapeutic targets for sleep and wake disorders. The human receptors hOX1R and hOX2R, which are 64% identical in sequence, have overlapping but distinct physiological functions and potential therapeutic profiles. We determined structures of hOX1R bound to the OX1R-selective antagonist SB-674042 and the dual antagonist suvorexant at 2.8-Å and 2.75-Å resolution, respectively, and used molecular modeling to illuminate mechanisms of antagonist subtype selectivity between hOX1R and hOX2R. The hOX1R structures also reveal a conserved amphipathic α-helix, in the extracellular N-terminal region, that interacts with orexin-A and is essential for high-potency neuropeptide activation at both receptors. The orexin-receptor crystal structures are valuable tools for the design and development of selective orexin-receptor antagonists and agonists.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26950369 DOI: 10.1038/nsmb.3183
Source DB: PubMed Journal: Nat Struct Mol Biol ISSN: 1545-9985 Impact factor: 15.369